NPDUIS Advisory Committee

Chair

Tanya Potashnik
Director, Policy and Economic Analysis Branch
Patented Medicine Prices Review Board

Members

Christine Voggenreiter
Director, Economic Analysis, Pharmaceutical Services Division
British Columbia Ministry of Health

Sandra Rees 
Manager, Drug Utilization and Agreements, Professional and Industry Relations
Alberta Health

Erin Jennings
Acting Manager, Strategic Financial Planning and Analysis
Drug Plan and Extended Benefits Branch, Saskatchewan Ministry of Health

Patricia Caetano
Executive Director, Provincial Drug Programs
Manitoba Health

Angie Wong
Senior Manager, Pharmaceutical Services Coordination
Ontario Public Drugs Programs

Kevin Pothier
Director, Business Management, Pharmaceutical Services
New Brunswick Department of Health

Holly Chisholm
Senior Economist
Nova Scotia Department of Health

Bonnie Corish
Pharmacist Consultant, Pharmacare Program
Health Prince Edward Island

Patricia Clark
Manager, Program Policy and Professional Services
Newfoundland and Labrador Department of Health and Community Services

Jodi Giesbrecht
Acting Manager, Extended Benefits and Pharmaceutical Programs
Yukon Department of Health and Social Services

Susan Pierce
Manager, Pharmacy Group, Benefit Management Division
Non-Insured Health Benefits Program

Nelson Millar
Senior Policy Analyst, Office of Pharmaceutical Management Strategies
Health Canada

Jeffrey Menzies
Manager, NPDUIS
Patented Medicine Prices Review Board

Elena Lungu
Manager, Policy Development
Patented Medicine Prices Review Board

Observers

Jordan Hunt
Manager, Pharmaceuticals
Canadian Institute for Health Information

Tarry Ahuja
Director, Health Economics
Canadian Agency for Drugs and Technologies in Health

Dominic Bélanger
Acting Director, Direction des affaires pharmaceutiques et du médicament
Ministère de la Santé et des Services sociaux du Québec

Daniel Sperber
Senior Economist
pan-Canadian Pharmaceutical Alliance Office